Bethpage Parent, Inc. /
Enzo Biochem, Inc.
Bethpage Parent takes Enzo Biochem private in completed merger
Source for the buyer and target: Enzo Biochem, Inc.
For the buyer and target.
“This Current Report on Form 8-K is being filed in connection with the completion of the previously announced Merger (as defined below) pursuant to the Agreement and Plan of Merger, dated as of June 23, 2025 (the “Merger Agreement”), by and among Enzo Biochem, Inc., a New York corporation (the “Company”), Bethpage Parent, Inc., a Delaware corporation (“Parent”), and Bethpage Merger Sub, Inc., a New York corporation and a wholly owned subsidiary of Parent (“Merger Sub”).”
Published 20 Aug 2025
Open the sourceWhat happened
Bethpage Parent, Inc. completed its merger with Enzo Biochem, Inc. on Aug. 20, 2025. Enzo Biochem survived as a wholly owned subsidiary of Bethpage Parent. [01]
Enzo Biochem shareholders were entitled to receive $0.70 in cash per share, subject to customary exceptions and applicable withholding taxes. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Bethpage Parent takes Enzo Biochem private in completed merger
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“Bethpage Parent takes Enzo Biochem private in completed merger Bethpage Parent, Inc. completed its merger with Enzo Biochem, Inc. on Aug. 20, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly